Academic Commons

Articles

Eosinophil and T cell markers predict functional decline in COPD patients

Wendt, Christine; Weinmann, Gail; Wise, Robert; Foronjy, Robert; Goldin, Jonathan; Louis, Thomas; Mao, Jenny; O'Connor, George; Ramsdell, Joe; Ries, Andrew; Schluger, Neil; Sciurba, Frank; Skeans, Melissa; Voelker, Helen; Walter, Robert; D'Armiento, Jeanine Marie; Scharf, Steven; Roth, Michael; Connett, John; Ghio, Andrew; Sternberg, David

The major marker utilized to monitor COPD patients is forced expiratory volume in one second (FEV1). However, a single measurement of FEV1 cannot reliably predict subsequent decline. Recent studies indicate that T lymphocytes and eosinophils are important determinants of disease stability in COPD. We therefore measured cytokine levels in the lung lavage fluid and plasma of COPD patients in order to determine if the levels of T cell or eosinophil related cytokines were predictive of the future course of the disease. Baseline lung lavage and plasma samples were collected from COPD subjects with moderately severe airway obstruction and emphysematous changes on chest CT. The study participants were former smokers who had not had a disease exacerbation within the past six months or used steroids within the past two months. Those subjects who demonstrated stable disease over the following six months (ΔFEV1 % predicted = 4.7 ± 7.2; N = 34) were retrospectively compared with study participants who experienced a rapid decline in lung function (ΔFEV1 % predicted = -16.0 ± 6.0; N = 16) during the same time period and with normal controls (N = 11). Plasma and lung lavage cytokines were measured from clinical samples using the Luminex multiplex kit which enabled the simultaneous measurement of several T cell and eosinophil related cytokines. Stable COPD participants had significantly higher plasma IL-2 levels compared to participants with rapidly progressive COPD (p = 0.04). In contrast, plasma eotaxin-1 levels were significantly lower in stable COPD subjects compared to normal controls (p < 0.03). In addition, lung lavage eotaxin-1 levels were significantly higher in rapidly progressive COPD participants compared to both normal controls (p < 0.02) and stable COPD participants (p < 0.05). These findings indicate that IL-2 and eotaxin-1 levels may be important markers of disease stability in advanced emphysema patients. Prospective studies will need to confirm whether measuring IL-2 or eotaxin-1 can identify patients at risk for rapid disease progression.

Subjects

Files

  • thumnail for 14100e4c403ae6f9e655bf7db08f1a7d.zip 14100e4c403ae6f9e655bf7db08f1a7d.zip binary/octet-stream 339 KB Download File

Also Published In

Title
Respiratory Research
DOI
https://doi.org/10.1186/1465-9921-10-113

More About This Work

Academic Units
Medicine
Publisher
BioMed Central
Published Here
September 8, 2014
Academic Commons provides global access to research and scholarship produced at Columbia University, Barnard College, Teachers College, Union Theological Seminary and Jewish Theological Seminary. Academic Commons is managed by the Columbia University Libraries.